|
ITGB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.644400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.767200E-01 |
| Normal-vs-Stage2 |
2.489400E-01 |
| Normal-vs-Stage3 |
1.174960E-01 |
| Normal-vs-Stage4 |
2.698400E-01 |
| Stage1-vs-Stage2 |
3.830400E-01 |
| Stage1-vs-Stage3 |
1.577600E-01 |
| Stage1-vs-Stage4 |
2.345600E-01 |
| Stage2-vs-Stage3 |
5.177000E-01 |
| Stage2-vs-Stage4 |
6.384200E-01 |
| Stage3-vs-Stage4 |
9.283200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.470800E-01 |
| Normal-vs-AfricanAmerican |
1.058390E-01 |
| Normal-vs-Asian |
4.652600E-01 |
| Caucasian-vs-AfricanAmerican |
4.876200E-01 |
| Caucasian-vs-Asian |
9.311600E-01 |
| AfricanAmerican-vs-Asian |
8.612200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.189600E-01 |
| Normal-vs-Female |
5.773700E-04 |
| Male-vs-Female |
2.996700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.027400E-01 |
| Normal-vs-Extreme_Weight |
7.205800E-01 |
| Normal-vs-Obese |
4.306000E-02 |
| Normal-vs-Extreme_Obese |
2.961200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.319200E-01 |
| Normal_Weight-vs-Obese |
1.295030E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.328600E-01 |
| Extreme_Weight-vs-Obese |
1.611630E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.662400E-01 |
| Obese-vs-Extreme_Obese |
1.282170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.232100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.091560E-02 |
| Normal-vs-Age(61-80Yrs) |
9.802200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.383600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.794000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.265800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.197900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.242900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.612900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.653900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.791550E-01 |
| Normal-VS-Type2 PRCC |
1.798410E-01 |
| Normal-VS-KIRP CIMP |
6.421100E-03 |
| Normal-VS-Unclassified PRCC |
1.024620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.295620E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.396800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.323400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.084500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.085560E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.513780E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.659600E-01 |
| Normal-vs-N1 |
4.118200E-02 |
| Normal-vs-N2 |
2.209200E-01 |
| N0-vs-N1 |
3.916200E-02 |
| N0-vs-N2 |
2.659800E-02 |
| N1-vs-N2 |
6.707000E-01 |
|
|
